Winway Health Desk
Merck KGaA antes up €250M to bridge R&D with manufacturing
Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing.
The German drugmaker today said...
New sickle cell drugs from Novartis, GBT need big discounts: ICER...
When Global Blood Therapeutics won approval for its new sickle cell disease drug Oxbryta last year, execs predicted a “paradigm shift” in the way patients are treated....
What the 2020 Democratic presidential candidates are getting right (and wrong)...
(L-R) Tom Steyer, Sen. Elizabeth Warren (D-MA), former Vice President Joe Biden, Sen. Bernie Sanders (I-VT), former South Bend, Indiana Mayor Pete Buttigieg, Sen....
China repurposes AbbVie HIV drug as Big Pharma rallies to combat...
To battle the coronavirus emergency, Chinese government and medical experts are taking some unconventional measures, including publicly backing off-label use of a Big Pharma...
Krystal Biotech investing up to $90M on facility for its gene...
Krystal Biotech is confident enough about its pipeline of candidates of gene therapies for treating skin diseases that has started work on a new...
Allergan to divest two drugs to satisfy regulators in $63B acquisition...
A drugmaker in one of the largest acquisition deals announced last year is offloading an investigational treatment for autoimmune disease and an approved drug...
Switching to a Plant Based Diet? 6 Tips on How to...
If you’re thinking about switching to a plant based diet, it can seem a bit daunting. But all you need are a few tips...
Eli Lilly, Incyte’s Olumiant notches another atopic dermatitis win. But can...
Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis with a suite of phase 3 studies—and it just...
Report: J&J ‘pretty confident’ it can develop coronavirus vaccine, exec says
A health worker checks the temperature of a man entering the Beijing subway on Jan. 26, 2020. The Chinese government has struggled to contain...
Call for FDA to withdraw preterm birth drug divides doctors and...
Doctors fear that the only drug approved to prevent preterm birth, the nation’s leading cause of infant mortality and disability, will no longer be...
